Trademark: 97727259
Word
ARGENX
Status Date
Thursday, May 16, 2024
Filing Date
Wednesday, December 21, 2022
Published for Opposition
Tuesday, June 18, 2024
5 Pharmaceuticals and medical preparations in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
35 Wholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namely, providing consumer product information in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information, namely, providing consumer product information relating to pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs
44 Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products
42 Research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research, design, analysis, and testing in the field of immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development
The mark consists of the word "ARGENX" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.
The color(s) dark gray, green, and dark green is/are claimed as a feature of the mark.
Jun 6, 2023
Non-Final Action Written
Dec 24, 2022
New Application Entered
Jan 18, 2023
New Application Office Supplied Data Entered
Jan 19, 2023
Notice Of Design Search Code E-Mailed
May 4, 2023
Assigned To Examiner
Jun 6, 2023
Non-Final Action E-Mailed
Jun 6, 2023
Notification Of Non-Final Action E-Mailed
Jul 14, 2023
Teas Response To Office Action Received
Jul 14, 2023
Correspondence Received In Law Office
Jul 14, 2023
Teas/Email Correspondence Entered
Oct 19, 2023
Suspension Letter Written
Oct 19, 2023
Letter Of Suspension E-Mailed
Oct 19, 2023
Notification Of Letter Of Suspension E-Mailed
Apr 19, 2024
Suspension Checked - To Attorney For Action
May 15, 2024
Inquiry To Suspension E-Mailed
Apr 22, 2024
Teas Response To Suspension Inquiry Received
Apr 24, 2024
Suspension Checked - To Attorney For Action
May 15, 2024
Notification Of Inquiry As To Suspension E-Mailed
May 15, 2024
Suspension Inquiry Written
May 16, 2024
Approved For Pub - Principal Register
May 16, 2024
Correspondence Received In Law Office
May 16, 2024
Teas/Email Correspondence Entered
Trademark Alertz updated from USPTO on 2030-01-24
